SpeeDx Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 84

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $22.2M

  • Investors
  • 14

SpeeDx General Information

Description

Developer of a molecular diagnostics test portfolio designed to provide innovative multiplex systems for clinical diagnostics. The company's test portfolio uses real-time polymerase chain reaction technology for multiplex detection and priming strategies, enabling physicians to test infectious disease and antibiotic resistance.

Contact Information

Website
www.plexpcr.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • National Innovation Centre, 4 Cornwallis Street
  • Suite 102
  • Eveleigh, New South Wales 2015
  • Australia
+61 (02)
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Vertical(s)
Digital Health, HealthTech, Life Sciences
Corporate Office
  • National Innovation Centre, 4 Cornwallis Street
  • Suite 102
  • Eveleigh, New South Wales 2015
  • Australia
+61 (02)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SpeeDx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Later Stage VC 28-Feb-2023 $22.2M Completed Generating Revenue
12. Secondary Transaction - Private Completed Generating Revenue
11. Grant 10-May-2021 Completed Generating Revenue
10. Later Stage VC (Series B) 11-Feb-2020 Completed Generating Revenue
9. Later Stage VC 05-Aug-2019 Completed Generating Revenue
8. Later Stage VC (Series A) 23-Apr-2019 Completed Generating Revenue
7. Later Stage VC 01-Jan-2018 Completed Generating Revenue
6. Grant 04-Sep-2017 Completed Generating Revenue
5. Grant 01-Aug-2016 $753K Completed Generating Revenue
4. Grant 01-Jul-2016 Completed Generating Revenue
To view SpeeDx’s complete valuation and funding history, request access »

SpeeDx Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
PREFERRED SERIES B
PREFERRED SERIES A
To view SpeeDx’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

SpeeDx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a molecular diagnostics test portfolio designed to provide innovative multiplex systems for clinical diagno
Diagnostic Equipment
Eveleigh, Australia
84 As of 2024

Cincinnati, OH
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

SpeeDx Competitors (7)

One of SpeeDx’s 7 competitors is Meridian Bioscience, a Private Equity-Backed company based in Cincinnati, OH.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Meridian Bioscience Private Equity-Backed Cincinnati, OH
Illumina Formerly VC-backed San Diego, CA
AusDiagnostics Private Equity-Backed Mascot, Australia
Cepheid Formerly VC-backed Sunnyvale, CA
Diagnostic Technology Corporation Belrose, Australia
You’re viewing 5 of 7 competitors. Get the full list »

SpeeDx Patents

  • 139

    Total Documents Applications and Grants

  • Total Patents Families

  • 96

    Granted

  • 19

    Pending

  • Expiring in next 12 mo

SpeeDx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024903744-A0 Temperature dependent probes for target detection Pending 14-Nov-2024
AU-2023901468-A0 Target detection using temperature controlled probes Pending 15-May-2023
AU-2024220029-A1 Target detection using temperature controlled probes Pending 15-May-2023
EP-4172355-A1 Multiplex detection of nucleic acids using mixed reporters Pending 30-Jun-2020
AU-2020256848-A1 Multiplex detection of nucleic acids using mixed reporters Pending 30-Jun-2020 C12Q1/6818
To view SpeeDx’s complete patent history, request access »

SpeeDx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SpeeDx Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
10K Lakes Capital PE/Buyout Minority
Tenmile Venture Capital Minority
West Midlands Pension Fund Limited Partner Minority
CARB-X University
Illumina Ventures Venture Capital Minority
You’re viewing 5 of 14 investors. Get the full list »

Ready to get started?

Request a free trial

SpeeDx FAQs

  • When was SpeeDx founded?

    SpeeDx was founded in 2009.

  • Where is SpeeDx headquartered?

    SpeeDx is headquartered in Eveleigh, Australia.

  • What is the size of SpeeDx?

    SpeeDx has 84 total employees.

  • What industry is SpeeDx in?

    SpeeDx’s primary industry is Diagnostic Equipment.

  • Is SpeeDx a private or public company?

    SpeeDx is a Private company.

  • What is SpeeDx’s current revenue?

    The current revenue for SpeeDx is .

  • How much funding has SpeeDx raised over time?

    SpeeDx has raised $62.3M.

  • Who are SpeeDx’s investors?

    10K Lakes Capital, Tenmile, West Midlands Pension Fund, CARB-X, and Illumina Ventures are 5 of 14 investors who have invested in SpeeDx.

  • Who are SpeeDx’s competitors?

    Meridian Bioscience, Illumina, AusDiagnostics, Cepheid, and Diagnostic Technology are some of the 7 competitors of SpeeDx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »